SEC Company Response from EXAGEN INC. (XGN) (CIK 0001274737) (XGN) — Nov 17, 2020
EXAGEN INC. (XGN) (CIK 0001274737)
Date: Nov. 17, 2020 · CIK: 0001274737 · Accession: 0001274737-20-000101
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-250015
Letter
Document
Exagen Inc.
1261 Liberty Way
Vista, California 92081
November 17, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Exagen Inc. Registration Statement on Form S-3
File No. 333-250015
Ladies and Gentlemen:
Pursuant to Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, on behalf of Exagen Inc., respectfully requests that the effective date of the Registration Statement on Form S-3 referred to above be accelerated so that it will become effective at 4:00 P.M. Eastern Time on November 19, 2020, or as soon as practicable thereafter.
If you have any questions or require additional information, please contact Matthew T. Bush, Esq. of Latham & Watkins LLP at (858) 523-3962. Thank you for your assistance and cooperation in this matter.
Very truly yours,
EXAGEN INC.
Show Raw Text
CORRESP 1 filename1.htm Document Exagen Inc. 1261 Liberty Way Vista, California 92081 November 17, 2020 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Exagen Inc. Registration Statement on Form S-3 File No. 333-250015 Ladies and Gentlemen: Pursuant to Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, on behalf of Exagen Inc., respectfully requests that the effective date of the Registration Statement on Form S-3 referred to above be accelerated so that it will become effective at 4:00 P.M. Eastern Time on November 19, 2020, or as soon as practicable thereafter. If you have any questions or require additional information, please contact Matthew T. Bush, Esq. of Latham & Watkins LLP at (858) 523-3962. Thank you for your assistance and cooperation in this matter. Very truly yours, EXAGEN INC. By: /s/ Kamal Adawi Kamal Adawi Chief Financial Officer cc: Matthew T. Bush, Latham & Watkins LLP Jeffrey T. Woodley, Latham & Watkins LLP